PATENT CLAIM ANALYSIS

Application Number: 15904269
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "093200"]

Abstract:
CRISPR/CAS-related compositions and methods for treatment of Leber's Congenital Amaurosis 10 (LCA10) are disclosed.

Claim (Index 21):
The method of  claim 18 , wherein said first targeting domain of said first gRNA molecule comprises the nucleotide sequence of SEQ ID NO:538 (CEP290-492) and said second targeting domain of said second gRNA molecule comprises a nucleotide sequence selected from the group consisting of SEQ ID NO:586 (CEP290-502) and SEQ ID NO:568 (CEP290-504).

Metadata:
- Claim Count in Document: 77.0
- Percentile: 88.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14644181', '15825616', '14536319', '15832567', '15127087']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.779948123703905
- 35 USC 102 Novelty (BERT): 0.7812337182870842
- Combined Prediction Score: 0.7800766831622229
- Mean Citation Score: 565.7883320000002
- Max Citation Score: 909.1263
- Similarity Product: 891.9294196036042

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test